Schonfeld Strategic Advisors’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-759,393
| Closed | -$2.19M | – | 2167 |
|
|
2023
Q3 | $2.19M | Buy |
759,393
+215,706
| +40% | +$621K | 0.02% | 695 |
|
|
2023
Q2 | $2.07M | Sell |
543,687
-69,492
| -11% | -$265K | 0.02% | 741 |
|
|
2023
Q1 | $1.14M | Buy |
613,179
+238,338
| +64% | +$443K | 0.01% | 898 |
|
|
2022
Q4 | $862K | Buy |
374,841
+104,668
| +39% | +$241K | 0.01% | 1224 |
|
|
2022
Q3 | $870K | Buy |
270,173
+12,249
| +5% | +$39.4K | 0.01% | 1340 |
|
|
2022
Q2 | $1.42M | Buy |
+257,924
| New | +$1.42M | 0.01% | 802 |
|
|
2021
Q3 | – | Sell |
-37,413
| Closed | -$486K | – | 2416 |
|
|
2021
Q2 | $486K | Sell |
37,413
-15,900
| -30% | -$207K | 0.01% | 1175 |
|
|
2021
Q1 | $822K | Buy |
+53,313
| New | +$822K | 0.01% | 933 |
|